[
  {
    "ts": "2025-09-18T20:21:00+00:00",
    "headline": "Incyte Announces Additional FDA Approval of Opzelura® (Ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis",
    "summary": "WILMINGTON, Del., September 18, 2025--Incyte Announces Additional FDA Approval of Opzelura® (Ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis",
    "url": "https://finance.yahoo.com/news/incyte-announces-additional-fda-approval-202100184.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "9d1a0a3d-df1a-3624-a869-24b6b96f58c3",
      "content": {
        "id": "9d1a0a3d-df1a-3624-a869-24b6b96f58c3",
        "contentType": "STORY",
        "title": "Incyte Announces Additional FDA Approval of Opzelura® (Ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis",
        "description": "",
        "summary": "WILMINGTON, Del., September 18, 2025--Incyte Announces Additional FDA Approval of Opzelura® (Ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis",
        "pubDate": "2025-09-18T20:21:00Z",
        "displayTime": "2025-09-18T20:21:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/094e053ea69d8e9c6e5fabef78465ecc",
          "originalWidth": 912,
          "originalHeight": 249,
          "caption": "OpzeluraⓇ (ruxolitinib) cream 1.5% logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TBqp5.OPJRU1VXmIQVeDMw--~B/aD0yNDk7dz05MTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/094e053ea69d8e9c6e5fabef78465ecc.cf.webp",
              "width": 912,
              "height": 249,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cBJLeVZKk9QDSZDWz4cwiQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/094e053ea69d8e9c6e5fabef78465ecc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/incyte-announces-additional-fda-approval-202100184.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/incyte-announces-additional-fda-approval-202100184.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "INCY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]